| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,343 |
4,843 |
$437K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,675 |
4,292 |
$339K |
| 92552 |
|
1,617 |
1,452 |
$36K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
255 |
245 |
$31K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
245 |
242 |
$27K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
250 |
238 |
$27K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
645 |
537 |
$27K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
235 |
210 |
$26K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
274 |
169 |
$20K |
| 94760 |
|
9,661 |
7,360 |
$17K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
443 |
329 |
$14K |
| 99000 |
|
4,607 |
3,614 |
$11K |
| 93000 |
|
779 |
666 |
$11K |
| 36415 |
Collection of venous blood by venipuncture |
4,745 |
3,958 |
$9K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
71 |
66 |
$9K |
| 99215 |
Prolong outpt/office vis |
63 |
60 |
$8K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
88 |
77 |
$8K |
| 90686 |
|
366 |
348 |
$8K |
| 99058 |
|
821 |
691 |
$7K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
765 |
725 |
$6K |
| 96127 |
|
1,018 |
877 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
318 |
190 |
$4K |
| 99173 |
|
1,660 |
1,502 |
$4K |
| 99050 |
|
291 |
246 |
$3K |
| 81025 |
|
554 |
495 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
176 |
114 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
171 |
112 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
318 |
143 |
$3K |
| 81003 |
|
1,748 |
1,490 |
$3K |
| 99051 |
|
505 |
418 |
$2K |
| 86580 |
|
300 |
268 |
$2K |
| 90647 |
|
88 |
83 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
37 |
29 |
$2K |
| 90670 |
|
80 |
73 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
141 |
96 |
$2K |
| 90734 |
|
76 |
59 |
$1K |
| 87563 |
|
106 |
67 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
29 |
26 |
$1K |
| 87430 |
|
105 |
93 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
15 |
12 |
$1K |
| 80061 |
Lipid panel |
123 |
102 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
58 |
40 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
190 |
153 |
$1K |
| 83655 |
|
89 |
85 |
$1K |
| 90723 |
|
45 |
40 |
$944.70 |
| 80053 |
Comprehensive metabolic panel |
137 |
103 |
$936.45 |
| 84443 |
Thyroid stimulating hormone (TSH) |
94 |
70 |
$867.90 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
129 |
105 |
$740.43 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
151 |
76 |
$706.44 |
| 90633 |
|
30 |
29 |
$663.73 |
| 96160 |
|
279 |
258 |
$637.08 |
| 90651 |
|
31 |
28 |
$628.56 |
| 90710 |
|
27 |
25 |
$582.00 |
| 86803 |
|
64 |
47 |
$554.40 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
65 |
57 |
$518.88 |
| 36410 |
|
55 |
51 |
$506.61 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
33 |
28 |
$485.24 |
| 97803 |
|
37 |
32 |
$447.95 |
| 90715 |
|
18 |
18 |
$425.98 |
| 86317 |
|
49 |
32 |
$361.86 |
| 99408 |
|
125 |
106 |
$343.00 |
| 83721 |
|
53 |
41 |
$322.34 |
| 84436 |
|
82 |
57 |
$322.14 |
| 87341 |
|
49 |
32 |
$310.26 |
| 84479 |
|
82 |
57 |
$303.02 |
| 90658 |
|
13 |
13 |
$279.36 |
| 90680 |
|
16 |
12 |
$256.08 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
14 |
12 |
$246.27 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
15 |
13 |
$194.54 |
| 84550 |
|
56 |
44 |
$167.80 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
26 |
24 |
$120.06 |
| 92551 |
|
22 |
12 |
$107.89 |
| 83540 |
|
49 |
32 |
$93.38 |
| 99442 |
|
46 |
42 |
$39.00 |
| 99401 |
|
15 |
14 |
$25.50 |
| 99441 |
|
50 |
30 |
$13.50 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
16 |
13 |
$0.56 |
| 0353U |
|
12 |
12 |
$0.00 |